ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)
CUSIP: 04280A100
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,223,624
- Total 13F shares
- 23,358,744
- Share change
- +8,301,346
- Total reported value
- $85,959,545
- Put/Call ratio
- 37%
- Price per share
- $3.68
- Number of holders
- 74
- Value change
- +$30,381,058
- Number of buys
- 46
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04280A100:
Top shareholders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OppenheimerFunds, Inc. |
13F
|
Company |
2.1%
|
3,000,000
|
$12,990,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
2,892,265
|
$12,524,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2%
|
2,859,169
|
$12,380,000 | — | 30 Sep 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.91%
|
1,272,138
|
$5,508,000 | — | 30 Sep 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.69%
|
971,768
|
$4,208,000 | — | 30 Sep 2017 | |
| ING GROEP NV |
13F
|
Company |
0.58%
|
808,229
|
$3,500,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
619,730
|
$2,683,000 | — | 30 Sep 2017 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.32%
|
452,120
|
$1,958,000 | — | 30 Sep 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.17%
|
234,500
|
$1,015,000 | — | 30 Sep 2017 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.17%
|
232,470
|
$1,006,000 | — | 30 Sep 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
200,000
|
$866,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.14%
|
194,974
|
$844,000 | — | 30 Sep 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
171,249
|
$742,000 | — | 30 Sep 2017 | |
| ELEMENT CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
142,649
|
$618,000 | — | 30 Sep 2017 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.08%
|
106,281
|
$425,000 | — | 30 Sep 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
91,002
|
$394,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
66,065
|
$286,000 | — | 30 Sep 2017 | |
| First Allied Advisory Services, Inc. |
13F
|
Company |
0.04%
|
61,000
|
$264,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
60,762
|
$263,000 | — | 30 Sep 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
57,965
|
$251,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
56,640
|
$245,000 | — | 30 Sep 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
44,358
|
$192,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
43,590
|
$189,000 | — | 30 Sep 2017 | |
| ProShare Advisors LLC |
13F
|
Company |
0.03%
|
42,114
|
$182,000 | — | 30 Sep 2017 | |
| WOLVERINE TRADING, LLC |
13F
|
Company |
0.03%
|
38,611
|
$167,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
35,501
|
$152,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
28,352
|
$123,000 | — | 30 Sep 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.02%
|
25,400
|
$110,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
20,750
|
$89,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
18,670
|
$81,000 | — | 30 Sep 2017 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.01%
|
18,664
|
$81,000 | — | 30 Sep 2017 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
18,008
|
$78,000 | — | 30 Sep 2017 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
16,400
|
$71,000 | — | 30 Sep 2017 | |
| Advisor Group, Inc. |
13F
|
Company |
0.01%
|
13,850
|
$60,000 | — | 30 Sep 2017 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
13,478
|
$58,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
11,898
|
$51,000 | — | 30 Sep 2017 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
10,952
|
$47,000 | — | 30 Sep 2017 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.01%
|
10,600
|
$46,000 | — | 30 Sep 2017 | |
| Edge Wealth Management LLC |
13F
|
Company |
0.01%
|
10,000
|
$43,000 | — | 30 Sep 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
7,208
|
$31,000 | — | 30 Sep 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
5,609
|
$24,000 | — | 30 Sep 2017 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0%
|
5,000
|
$21,000 | — | 30 Sep 2017 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
3,599
|
$16,000 | — | 30 Sep 2017 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,187
|
$14,000 | — | 30 Sep 2017 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
1,318
|
$6,000 | — | 30 Sep 2017 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
1,010
|
$4,000 | — | 30 Sep 2017 | |
| Financial Architects, Inc |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 30 Sep 2017 | |
| Wealthspire Advisors, L.P. |
13F
|
Company |
0%
|
700
|
$3,000 | — | 30 Sep 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
633
|
$3,000 | — | 30 Sep 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
600
|
$3,000 | — | 30 Sep 2017 |
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q4 2017
As of 31 Dec 2017,
ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,358,744 shares.
The largest 10 holders included
OppenheimerFunds, Inc., FIRST MANHATTAN CO, Vanguard Group Inc, BlackRock Inc., D. E. Shaw & Co., Inc., MILLENNIUM MANAGEMENT LLC, Uniplan Investment Counsel, Inc., GEODE CAPITAL MANAGEMENT, LLC, Allianz Asset Management GmbH, and PDT Partners, LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
54
Q4 2017 holders
74
Holder diff
20
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.